Genotypic Influences on Network Progression in Parkinson's Disease
Trial
N/A
Completed
Nov. 2, 2026
Expanded Access to Tavapadon
Trial
N/A
No longer available
Nov. 2, 2026
Neuroplasticity in Parkinson's Disease
Trial
N/A
Completed
Nov. 2, 2026
Automated Language Analysis in Neurodegenerative Diseases: Application of Artificial Intelligence Models
Trial
N/A
Recruiting
Nov. 2, 2026
A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis
Trial
Phase 3
Completed
Nov. 1, 2026
Exploratory Study About the Implementation of Technology in the Rehabilitation
Trial
N/A
Completed
Nov. 1, 2026
The Relationship Between Upper Extremity Function and Balance and Functional Mobility in Parkinson's Disease
Trial
N/A
Completed
Nov. 1, 2026
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
Trial
Phase 1
Recruiting
Nov. 1, 2026
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
Trial
Phase 3
Recruiting
Nov. 1, 2026
Safety and Tolerability of Single and Repeated Dose of IMM02-KORA in PD-associated Dyskinesia
Trial
Phase 1
Not yet recruiting
Oct. 29, 2026
AI-Based Differential Diagnosis and Localization of Tachycardia Using ECG: Multicenter Registry (EP-AI ASSIST)
Trial
N/A
Recruiting
Oct. 29, 2026
Investigating Basal Ganglia-Cortical Physiology During Sleep and Its Modulation by Adaptive Deep Brain Stimulation in Parkinson Disease
Trial
N/A
Recruiting
Oct. 29, 2026
A Study of Buntanetap in Participants With PD
Trial
Phase 2
Recruiting
Oct. 29, 2026
Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease
Trial
Phase 2
Completed
Oct. 29, 2026
Study of the Link Between Freezing of Gait and Oropharyngeal Freezing in Parkinson's Patients
Trial
N/A
Completed
Oct. 29, 2026
Dual Tasking Training to Enhance Self-Efficacy in Individuals With Parkinson's Disease
Trial
N/A
Recruiting
Oct. 29, 2026
Estimates of the Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson Disease
Trial
Phase 2
Not yet recruiting
Oct. 29, 2026
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
Trial
Phase 2
Recruiting
Oct. 29, 2026
Cognitive-Motor Training for Gait Adaptability in Parkinson Disease
Trial
N/A
Not yet recruiting
Oct. 29, 2026
Strength and Dual-Task on Sarcopenia in People With Parkinson's Disease
Trial
N/A
Recruiting
Oct. 29, 2026